Abstract
Murine monoclonal antibody CF511, raised against human ovarian clear cell carcinoma, detects a glycoprotein (Mr 600 kDa) called CF511 antigen which is elevated in the serum of many patients with ovarian carcinoma. A competitive enzyme-linked immunosorbent assay was developed to detect CF511 antigen in human serum and used to detected CF511 antigen in subjects with ovarian carcinoma and other diseases. No raised levels (less than 18 unit (U) ml-1) of the antigen were found in the serum of 220 normal individuals or of patients with germ cell tumours (n = 6), granulosa theca cell tumour (n = 1), gastric carcinomas (n = 10) and colo-rectal carcinomas (n = 8). Raised serum levels of CF511 antigen were found in 6/46 patients (13.0%) with benign gynaecological tumours (including endometriosis or ovarian cyst), in 5/7 patients (71.4%) with breast carcinoma and 16/21 (76.2%) lung carcinoma patients. In patients with ovarian carcinoma, 42.3% (11/26) of stage I and II, and 96.0% (24/25) of stage III and IV had levels of greater than or equal to 18 U ml-1. In all patients with serial determination of CF511 antigen levels before and after the surgery, the levels of antigen correlated with the clinical course of disease. Determination of CF511 antigen levels may be useful for detection of ovarian carcinoma as well as lung and breast carcinomas and for monitoring progress of disease and response to therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kishi M., Nakajo S., Shibayama T., Nakaya K., Nakamura Y. Cell surface proteins extracted with urea from AH-66 hepatoma ascites cells. J Biochem. 1980 Jan;87(1):135–141. doi: 10.1093/oxfordjournals.jbchem.a132718. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Niloff J. M., Knapp R. C., Schaetzl E., Reynolds C., Bast R. C., Jr CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol. 1984 Nov;64(5):703–707. [PubMed] [Google Scholar]
- Ohkawa K., Tsukada Y., Murae M., Kimura E., Takada K., Abe T., Terashima Y., Mitani K. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511. Br J Cancer. 1989 Dec;60(6):953–960. doi: 10.1038/bjc.1989.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takahashi K., Shibukawa T., Moriyama M., Shirai T., Kijima S., Iwanari O., Matsunaga I., Kitao M. Clinical usefulness and false-positive results of CA 125 as a tumor marker of ovarian cancer--a study on 674 patients. Jpn J Surg. 1986 Sep;16(5):305–310. doi: 10.1007/BF02470551. [DOI] [PubMed] [Google Scholar]
- Thor A., Ohuchi N., Szpak C. A., Johnston W. W., Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 1986 Jun;46(6):3118–3124. [PubMed] [Google Scholar]
- Zanaboni F., Vergadoro F., Presti M., Gallotti P., Lombardi F., Bolis G. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma. Gynecol Oncol. 1987 Sep;28(1):61–67. doi: 10.1016/s0090-8258(87)80009-4. [DOI] [PubMed] [Google Scholar]